{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:43:32Z","timestamp":1793108612515,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007653","name":"Universit\u00e4tsklinikum Jena","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007653","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pneumonia"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The main burden of non-invasive pneumococcal diseases in adults is largely due to community-acquired pneumonia (CAP). This study aimed to investigate the distribution and dynamics of pneumococcal vaccine serotypes and to determine the proportion of CAP cases attributable to serotypes covered by 13-valent conjugate vaccine (PCV13), the 20-valent conjugate vaccine (PCV20), and the 23-valent polysaccharide vaccine (PPV23) among adults in Germany from 2020 to 2023. In this prospective multicenter cohort study, we analyzed all adult patients with CAP enrolled between January 1, 2020, and December 31, 2023, at 26 centers in Germany who provided urine samples for serotype-specific urine antigen detection (SSUAD) testing. Annual trends of pneumococcal vaccine serotypes from 2020 to 2023 were calculated for all patients and patient groups at risk using cluster-robust generalized linear models with heteroscedasticity-consistent standard errors. Of the 2,028 patients with all-cause CAP, 1,504 (1,008 patients aged\u2009\u2265\u200960 years, 373 younger patients with at least one comorbidity) had urine samples analyzed with SSUAD tests. Overall proportion of vaccine-type pneumococcal pneumonia among all-cause CAP for PCV13, PCV20, and PPV23 serotypes was 5.41% (95% CI 4.12\u20137.06%), 8.11% (95% CI 6.35\u201310.31%), and 8.31% (95% CI 6.27\u201310.93%), and serotype 3 was the most prevalent serotype (52 cases). Among patients aged\u2009\u2265\u200960 years, an increasing annual trend was observed for serotype 3 (OR 1.84, 95% CI 1.01\u20132.67), PCV13 (OR 1.89, 95% CI 0.89\u20132.89), PCV20 (OR 1.57, 95% CI 0.99\u20132.14), and PPV23 serotypes (OR 1.47, 1.04\u20131.91). The findings demonstrate that vaccine serotypes, particularly serotype 3, continued to circulate and reemerged among older adults with CAP in Germany.<\/jats:p>","DOI":"10.1186\/s41479-026-00204-3","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:01:56Z","timestamp":1784934116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pneumococcal pneumonia in adults \u2013 re-emergence of vaccine serotypes: a prospective multicenter cohort study in Germany, 2020\u20132023"],"prefix":"10.1186","volume":"18","author":[{"given":"Christina","family":"Bahrs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grit","family":"Barten-Neiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Fleischmann-Struzek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P. G.","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Witzenrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Rademacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias W.","family":"Pletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the CAPNETZ Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Prasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. C.","family":"Diehl-Wiesenecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Galtung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Suttorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Witzenrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kodde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-M.","family":"Stoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Boesecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Breitschwerdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Benke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Schmager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gr\u00fcnewaldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Schaaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kremling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kolditz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Schulte-Hubbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ronczka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Seeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kohlh\u00e4ufl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Stolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"F\u00e4hndrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Panning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Unnewehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hoeper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Pink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Drick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"F\u00fchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Barten-Neiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Kr\u00f6ner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Unruh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Adaskina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Eberhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Illig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Klopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. W.","family":"Pletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. T.","family":"Schleenvoigt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Moeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Dr\u00f6mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Parschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Franzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Kadgien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"K\u00e4ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Boutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Erber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Voit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Heigener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Hering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Albrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Rassouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Neurohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Essig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Stenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wallner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Burgmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Traby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"204_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1055\/s-0032-1310103","volume":"66","author":"MW Pletz","year":"2012","unstructured":"Pletz MW, von Baum H, van der Linden M, Rohde G, Sch\u00fctte H, Suttorp N, et al. The burden of pneumococcal pneumonia - experience of the German competence network CAPNETZ. Pneumologie. 2012;66:470\u20135. https:\/\/doi.org\/10.1055\/s-0032-1310103.","journal-title":"Pneumologie"},{"key":"204_CR2","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1055\/s-0036-1592074","volume":"37","author":"C Feldman","year":"2016","unstructured":"Feldman C, Anderson R. The role of streptococcus pneumoniae in community-acquired pneumonia. Semin Respir Crit Care Med. 2016;37:806\u201318. https:\/\/doi.org\/10.1055\/s-0036-1592074.","journal-title":"Semin Respir Crit Care Med"},{"key":"204_CR3","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1080\/22221751.2021.1957402","volume":"10","author":"T D\u00e4hne","year":"2021","unstructured":"D\u00e4hne T, Bauer W, Essig A, Schaaf B, Spinner CD, Pletz MW, et al. The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany. Emerg Microbes Infect. 2021;10:1515\u20138. https:\/\/doi.org\/10.1080\/22221751.2021.1957402.","journal-title":"Emerg Microbes Infect"},{"key":"204_CR4","doi-asserted-by":"publisher","first-page":"00703","DOI":"10.1183\/23120541.00703-2022","volume":"9","author":"J Ankert","year":"2023","unstructured":"Ankert J, Hagel S, Schwarz C, Pan K, Wang L, von Eiff C, et al. Streptococcus pneumoniae re-emerges as a cause of community-acquired pneumonia, including frequent co-infection with SARS-CoV-2, in Germany, 2021. ERJ Open Res. 2023;9:00703\u20132022. https:\/\/doi.org\/10.1183\/23120541.00703-2022.","journal-title":"ERJ Open Res"},{"key":"204_CR5","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/cid\/cix1066","volume":"66","author":"RG Wunderink","year":"2018","unstructured":"Wunderink RG, Self WH, Anderson EJ, Balk R, Fakhran S, Courtney DM, et al. Pneumococcal Community-Acquired Pneumonia Detected by Serotype-Specific Urinary Antigen Detection Assays. Clin Infect Dis. 2018;66:1504\u201310. https:\/\/doi.org\/10.1093\/cid\/cix1066.","journal-title":"Clin Infect Dis"},{"key":"204_CR6","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1128\/CVI.00064-12","volume":"19","author":"MW Pride","year":"2012","unstructured":"Pride MW, Huijts SM, Wu K, Souza V, Passador S, Tinder C, et al. Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urine. Clin Vaccine Immunol. 2012;19:1131\u201341. https:\/\/doi.org\/10.1128\/CVI.00064-12.","journal-title":"Clin Vaccine Immunol"},{"key":"204_CR7","doi-asserted-by":"publisher","first-page":"e430","DOI":"10.1093\/cid\/ciaa158","volume":"71","author":"WV Kalina","year":"2020","unstructured":"Kalina WV, Souza V, Wu K, Giardina P, McKeen A, Jiang Q, et al. Qualification and Clinical Validation of an Immunodiagnostic Assay for detecting 11 additional Streptococcus pneumoniae Serotype-specific Polysaccharides in Human Urine. Clin Infect Dis. 2020;71:e430\u20138. https:\/\/doi.org\/10.1093\/cid\/ciaa158.","journal-title":"Clin Infect Dis"},{"key":"204_CR8","doi-asserted-by":"publisher","first-page":"2102432","DOI":"10.1183\/13993003.02432-2021","volume":"59","author":"C Bahrs","year":"2022","unstructured":"Bahrs C, Kesselmeier M, Kolditz M, Ewig S, Rohde G, Barten-Neiner G, et al. A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany. Eur Respir J. 2022;59:2102432. https:\/\/doi.org\/10.1183\/13993003.02432-2021.","journal-title":"Eur Respir J"},{"key":"204_CR9","doi-asserted-by":"publisher","unstructured":"German Standing committee on vaccination at the robert Koch Institute. Recommendation of the standing committee on vaccination (STIKO) at the Robert Koch Institute\u2009\u2013\u20092016\/2017. Epi Bull. 2016;34. https:\/\/doi.org\/10.17886\/EPIBULL-2016-072.","DOI":"10.17886\/EPIBULL-2016-072"},{"key":"204_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/00031305.1992.10475842","volume":"46","author":"GW Oehlert","year":"1992","unstructured":"Oehlert GW. A note on the delta method. Am Stat. 1992;46:27\u20139.","journal-title":"Am Stat"},{"key":"204_CR11","unstructured":"R Core Team. R: A language and environment for statistical computing. In, Vienna. Austria: R Foundation for statistical computing. 2025."},{"key":"204_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.eclinm.2018.12.007","volume":"6","author":"A Djennad","year":"2019","unstructured":"Djennad A, Ramsay ME, Pebody R, Fry NK, Sheppard C, Ladhani SN, et al. Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine and Changes in Invasive Pneumococcal Disease Incidence from 2000 to 2017 in Those Aged 65 and Over in England and Wales. EClinicalMedicine. 2019;6:42\u201350. https:\/\/doi.org\/10.1016\/j.eclinm.2018.12.007.","journal-title":"EClinicalMedicine"},{"key":"204_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2025.08.014","author":"C Bahrs","year":"2025","unstructured":"Bahrs C, Andreas N, Lehmann T, Baumgart S, J\u00f8rgensen CS, Makarewicz O, et al. A randomized trial of simultaneous versus sequential pneumococcal vaccination in elderly. Clin Microbiol Infect. 2025;31:2003-10. https:\/\/doi.org\/10.1016\/j.cmi.2025.08.014","journal-title":"Clin Microbiol Infect"},{"key":"204_CR14","doi-asserted-by":"publisher","first-page":"e0008225","DOI":"10.1128\/msphere.00082-25","volume":"10","author":"ST Almeida","year":"2025","unstructured":"Almeida ST, Paulo AC, Sim\u00f5es AS, Ferreira B, S\u00e1-Le\u00e3o R. Streptococcus pneumoniae carriage in adults during the COVID-19 pandemic in Portugal: dominance of serotypes included in broader PCVs and of serotype 3. mSphere. 2025;10:e0008225. https:\/\/doi.org\/10.1128\/msphere.00082-25.","journal-title":"mSphere"},{"key":"204_CR15","doi-asserted-by":"publisher","first-page":"2469424","DOI":"10.1080\/21645515.2025.246924","volume":"21","author":"H Maeda","year":"2025","unstructured":"Maeda H, Morimoto K. Global distribution and characteristics of pneumococcal serotypes in adults. Hum Vaccin Immunother. 2025;21:2469424. https:\/\/doi.org\/10.1080\/21645515.2025.246924.","journal-title":"Hum Vaccin Immunother"},{"key":"204_CR16","doi-asserted-by":"publisher","first-page":"2563953","DOI":"10.1080\/21645515.2025.2563953","volume":"21","author":"M Chiavarini","year":"2025","unstructured":"Chiavarini M, Boccalini S, Bechini A, Barash A, Castellana E, Senape A, et al. Pneumococcal vaccination offer and schedules in adults in EU countries: An update. Hum Vaccin Immunother. 2025;21:2563953. https:\/\/doi.org\/10.1080\/21645515.2025.2563953.","journal-title":"Hum Vaccin Immunother"},{"key":"204_CR17","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S1473-3099(24)00344-X","volume":"24","author":"HL Platt","year":"2024","unstructured":"Platt HL, Bruno C, Buntinx E, Pelayo E, Garcia-Huidobro D, Barranco-Santana EA, et al. Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial. Lancet Infect Dis. 2024;24:1141\u201350. https:\/\/doi.org\/10.1016\/S1473-3099(24)00344-X.","journal-title":"Lancet Infect Dis"},{"key":"204_CR18","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00946-2025","author":"D Karssen","year":"2025","unstructured":"Karssen D, Hessels LM, Barten-Neiner G, Bauer W, Franch-Arroyo S, F\u00fchner T, et al. Serotype distribution and coverage by pneumococcal vaccines in hospitalized adults with pneumococcal pneumonia in Germany. ERJ Open Res. 2026;12:00946-2025. https:\/\/doi.org\/10.1183\/23120541.00946-2025","journal-title":"ERJ Open Res"},{"key":"204_CR19","doi-asserted-by":"publisher","first-page":"100812","DOI":"10.1016\/j.lanepe.2023.100812","volume":"37","author":"L Lansbury","year":"2023","unstructured":"Lansbury L, Lawrence H, McKeever TM, French N, Aston S, Hill AT, et al. Pneumococcal serotypes and risk factors in adult community-acquired pneumonia 2018-20; a multicentre UK cohort study. Lancet Reg Health Eur. 2023;37:100812. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100812.","journal-title":"Lancet Reg Health Eur"}],"container-title":["Pneumonia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-026-00204-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41479-026-00204-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41479-026-00204-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:01:58Z","timestamp":1784934118000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41479-026-00204-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["204"],"URL":"https:\/\/doi.org\/10.1186\/s41479-026-00204-3","relation":{},"ISSN":["2200-6133"],"issn-type":[{"value":"2200-6133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Research was conducted in accordance with the Declaration of Helsinki and national and institutional standards. The study protocol was approved by the local ethics committees of all participating centers (number of leading ethics committee Medical Faculty of Otto-von-Guericke-University Magdeburg: 104\/01; see acknowledgment or\n                      \n                      for participating centers). Prior to study enrolment, all patients provided written informed consent. As only anonymised data were analysed, additional consent to publish was not required.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"C.B. is a member of the scientific advisory board of GSK, has received personal fees for lectures from GSK and has received support for attending meetings and travel from Pfizer, all outside the submitted work. G.B-N. reports economic connections to the following diagnostic and pharmaceutical companies: GSK, Merck Sharp & Dohme Corp., Pfizer, R-Biopharm AG and Helmut Hund GmbH. M.P.G.L. has been a member of advisory boards for Pfizer, Merck\/MSD and GSK, and has received lecture fees and research grants from Pfizer and Merck\/MSD. GR reports personal fees from Astrazeneca, Berlin Chemie, BMS, Pfizer, Boehringer Ingelheim, Solvay, Insmed, GSK, Essex Pharma, MSD, Grifols, Chiesi, Vertex, Roche, Takeda and Novartis for lectures including service on speakers\u2019 bureaus outside the submitted work and\/or consultancy during advisory board meetings and personal fees from GSK for travel accommodations\/meeting expenses, outside the submitted work. MW received personal fees from Astrazeneca, Bayer Health Care, Berlin Chemie, Biotest, Chiesi, Novartis, Teva, and research funding from Actelion, Bayer Health Care, Biotest, Boehringer Ingelheim, all unrelated to the current work. Je.Ra. received research support from Bundesministerium f\u00fcr Bildung und Forschung (BMBF), Bundesministerium f\u00fcr Gesundheit (BMG), Infectopharm; lecture fees from AstraZeneca, GSK, Chiesi, Esanum, Novartis, ThermoFisher, Berlin-Chemie, MSD, Boehringer, Pfizer, Shionogi; Sanofi, Consultant fees from Shionogi, GSK, Advanz, Gilead, MSD. M. W. P is a consultant to and has received speaker honoraria from GSK, MSD, Pfizer, Biomerieux, Moderna, Astrazeneca and Thermofisher and has received research grants from Pfizer. N. R., C. F-S., J. R. have declared no conflict of interest.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"16"}}